[2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl]amine hydrochloride hydrate, 95.0%, 250mg

2-Chloro-6-(2,2,2-trifluoroethoxy)pyrazine, 95.0%, 5g

6-Chloro-2-methyl-quinoline-4-carboxylic acid, 95.0%, 1g

Lithium chloride, min. 99%, pa, ACS, 100 g, plastic packaging.

4-Methoxy-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile, 97%, 1g

(S)-(-)-3-(tert-Butoxycarbonyl)-4-formyl-2,2-dimethyl-1,3-oxazolidine>95.0%(GC)1g

2-(2-Bromo-4-chlorophenyl)-1,3-dioxolane, 98%, 5g

4'-Bromomethyl-2-cyanobiphenyl>98.0%(GC)5g

5-Bromo-4-methylisothiazole, 95.0%, 2.5g

Boc-L-Isoleucine, 98.0%, 100g

2-(3-Bromo-5-isobutoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 100mg

(1-Methyl-piperidin-4-yl)acetic acid ethyl ester, 95.0%, 10g

6-CYCLOPROPYL-3-PYRIDAZINONE, 97.0%, 5g